The Advisory Board Co. (ABCO) Stock Price Up 0.9%
The Advisory Board Co. (NASDAQ:ABCO)’s share price rose 0.9% during mid-day trading on Wednesday . The stock traded as high as $42.81 and last traded at $42.42, with a volume of 170,615 shares trading hands. The stock had previously closed at $42.06.
Several equities research analysts have recently commented on the company. Canaccord Genuity reissued a “buy” rating and issued a $50.00 target price on shares of The Advisory Board in a research note on Friday, May 6th. Zacks Investment Research raised The Advisory Board from a “hold” rating to a “buy” rating and set a $35.00 target price for the company in a research note on Tuesday, April 26th. SunTrust Banks Inc. lifted their target price on The Advisory Board from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, May 12th. Craig Hallum raised The Advisory Board from a “hold” rating to a “buy” rating and set a $47.00 target price for the company in a research note on Thursday, July 28th. Finally, Oppenheimer Holdings Inc. set a $45.00 target price on The Advisory Board and gave the company a “buy” rating in a research note on Thursday, July 28th. Five research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The Advisory Board currently has an average rating of “Buy” and a consensus target price of $42.73.
The firm’s market capitalization is $1.71 billion. The stock’s 50-day moving average price is $40.00 and its 200-day moving average price is $34.62.
The Advisory Board (NASDAQ:ABCO) last announced its quarterly earnings results on Wednesday, July 27th. The company reported $0.47 EPS for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.13. During the same quarter in the previous year, the company posted $0.40 earnings per share. The firm earned $198.40 million during the quarter, compared to the consensus estimate of $196.49 million. The firm’s revenue was up 7.4% on a year-over-year basis. Equities analysts predict that The Advisory Board Co. will post $1.86 EPS for the current year.
In other news, CFO Michael T. Kirshbaum sold 2,400 shares of the stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $41.53, for a total value of $99,672.00. Following the completion of the transaction, the chief financial officer now directly owns 40,703 shares in the company, valued at approximately $1,690,395.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kelt Kindick purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The stock was purchased at an average price of $32.81 per share, with a total value of $164,050.00. Following the completion of the purchase, the director now directly owns 22,662 shares in the company, valued at approximately $743,540.22. The disclosure for this purchase can be found here.
An institutional investor recently raised its position in The Advisory Board stock. King Luther Capital Management Corp boosted its position in shares of The Advisory Board Co. (NASDAQ:ABCO) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 304,920 shares of the company’s stock after buying an additional 6,380 shares during the period. King Luther Capital Management Corp owned approximately 0.73% of The Advisory Board worth $15,127,000 at the end of the most recent quarter.
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.